Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera (RAMP)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Calabria
-
Cosenza, Calabria, Italy, 87100
- Azienda Ospedaliera Annunziata
-
Reggio Calabria, Calabria, Italy, 89124
- Grande Ospedale Metropolitano "Bianchi Melacrino Morelli"
-
-
Campania
-
Napoli, Campania, Italy, 80131
- Università degli Studi di Napoli Federico II - U.O.C. di Ematologia e Trapianti di midollo
-
-
Emilia Romagna
-
Bologna, Emilia Romagna, Italy, 40138
- IRCCS Policlinico Sant'Orsola
-
-
Emilia-Romagna
-
Ferrara, Emilia-Romagna, Italy, 44124
- Università degli studi di Ferrara - Nuovo Polo Ospedaliero di Cona - A.O.U. Arcispedale S. Anna
-
Parma, Emilia-Romagna, Italy, 43126
- Azienda Ospedaliero-Universitaria di Parma
-
Piacenza, Emilia-Romagna, Italy, 29121
- AUSL di Piacenza - Palazzine Medicine Specialistiche
-
Ravenna, Emilia-Romagna, Italy, 48121
- Dipartimento Oncoematologico - AUSL della Romagna
-
Reggio Emilia, Emilia-Romagna, Italy, 42123
- Arcispedale Santa Maria Nuova - IRCCS
-
Rimini, Emilia-Romagna, Italy, 47923
- Ospedale infermi di Rimini
-
-
Friuli-Venezia Giulia
-
Udine, Friuli-Venezia Giulia, Italy, 33100
- A.O.U. Integrata di Udine
-
-
Lazio
-
Roma, Lazio, Italy, 00144
- Ospedale S. Eugenio
-
Roma, Lazio, Italy, 00161
- A.O.U. Policlinico Umberto I - Università degli Studi di Roma "La Sapienza"
-
Viterbo, Lazio, Italy, 01100
- Ospedale Belcolle
-
-
Liguria
-
Genova, Liguria, Italy, 16132
- IRCCS Azienda Ospedaliera Universitaria "San Martino" - IST
-
-
Lombardia
-
Brescia, Lombardia, Italy, 25123
- ASST Spedali Civili di Brescia
-
Milano, Lombardia, Italy, 20122
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
-
Monza, Lombardia, Italy, 20900
- Ospedale San Gerardo
-
-
Marche
-
Pesaro, Marche, Italy, 61122
- A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore
-
-
Piemonte
-
Orbassano, Piemonte, Italy, 10043
- Ospedale San Luigi Gonzaga
-
Torino, Piemonte, Italy, 10124
- Department of Oncology, University of Torino
-
Torino, Piemonte, Italy, 10126
- A.O.U. Città della salute e della scienza - Presidio Molinette
-
Torino, Piemonte, Italy, 10128
- A. O. Ordine Mauriziano di Torino
-
-
Sardegna
-
Cagliari, Sardegna, Italy, 09131
- Ospedale "A. Businco" - Dipartimento Scienze Mediche e Sanità Pubblica Università degli Studi di Cagliari
-
-
Sicilia
-
Catania, Sicilia, Italy, 95124
- A.O.U. "Policlinico-V. Emanuele"- P.O. Ferrarotto
-
-
Toscana
-
Siena, Toscana, Italy, 53100
- Policlinico S.Maria alle Scotte
-
-
Veneto
-
Padova, Veneto, Italy, 35128
- AOU di Padova
-
Verona, Veneto, Italy, 37134
- A.O.U. Integrata Verona - Borgo Roma
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years
- Patients diagnosed with Primary Myelofibrosis or secondary to Essential Thrombocythemia/Polycythemia Vera or diagnosed with Polycythemia Vera who are in the treatment with ruxolitinib therapy in accordance with normal clinical practice
- Obtaining informed consent for data collection and processing
- The Patient must come to the in-person visit at least once, an occasion on which informed consent to 'study membership will be offered
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence
Time Frame: 2 years
|
Incidence of low adherence to ruxolitinib therapy, and the features associated with low adherence
|
2 years
|
|
Distress
Time Frame: 2 years
|
Emotional distress is measured based on a visual analogue scale with the distress thermometer, a simple and quick (3-4 minutes) tool that investigates the areas most involved in distress (minimum value: 0, lower distress; maximum value: 10, higher distress)
|
2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1064/2020/Oss/AOUBo
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.